CLINICAL_TRIALS
trial_result
· 2016-07-12
Clinical Trial Update: Bevacizumab in Metastatic Renal Cancer
Summary
A clinical trial evaluating bevacizumab in metastatic renal cell carcinoma has completed, and the results were posted in July 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Renal Cell Cancer | Status: COMPLETED | Results posted: 2016-07-12